Literature DB >> 11875246

Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Niall P A S Johnson, Juergen Mueller.   

Abstract

The influenza pandemic of 1918-20 is recognized as having generally taken place in three waves, starting in the northern spring and summer of 1918. This pattern of three waves, however, was not universal: in some locations influenza seems to have persisted into or returned in 1920. The recorded statistics of influenza morbidity and mortality are likely to be a significant understatement. Limitations of these data can include nonregistration, missing records, misdiagnosis, and nonmedical certification, and may also vary greatly between locations. Further research has seen the consistent upward revision of the estimated global mortality of the pandemic, which a 1920s calculation put in the vicinity of 21.5 million. A 1991 paper revised the mortality as being in the range 24.7-39.3 million. This paper suggests that it was of the order of 50 million. However, it must be acknowledged that even this vast figure may be substantially lower than the real toll, perhaps as much as 100 percent understated.

Mesh:

Year:  2002        PMID: 11875246     DOI: 10.1353/bhm.2002.0022

Source DB:  PubMed          Journal:  Bull Hist Med        ISSN: 0007-5140            Impact factor:   1.314


  489 in total

1.  Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

Authors:  Yanmei Hu; Jiantao Zhang; Rami Ghassan Musharrafieh; Chunlong Ma; Raymond Hau; Jun Wang
Journal:  Antiviral Res       Date:  2017-08-02       Impact factor: 5.970

2.  Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection.

Authors:  Sarah E Belisle; Jennifer R Tisoncik; Marcus J Korth; Victoria S Carter; Sean C Proll; David E Swayne; Mary Pantin-Jackwood; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak.

Authors:  Zong-Mei Sheng; Daniel S Chertow; Xavier Ambroggio; Sherman McCall; Ronald M Przygodzki; Robert E Cunningham; Olga A Maximova; John C Kash; David M Morens; Jeffery K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

4.  Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.

Authors:  Cristian Cilloniz; Mary J Pantin-Jackwood; Chester Ni; Victoria S Carter; Marcus J Korth; David E Swayne; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

5.  Changing perceptions: of pandemic influenza and public health responses.

Authors:  Adam Kamradt-Scott
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

6.  Mortality from the influenza pandemic of 1918-1919: the case of India.

Authors:  Siddharth Chandra; Goran Kuljanin; Jennifer Wray
Journal:  Demography       Date:  2012-08

Review 7.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

Review 8.  Influenza: the once and future pandemic.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Public Health Rep       Date:  2010-04       Impact factor: 2.792

9.  1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

Authors:  Kathie-Anne Walters; Felice D'Agnillo; Zong-Mei Sheng; Jason Kindrachuk; Louis M Schwartzman; Rolf E Kuestner; Daniel S Chertow; Basil T Golding; Jeffery K Taubenberger; John C Kash
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

10.  Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic.

Authors:  R N Thompson; C P Thompson; O Pelerman; S Gupta; U Obolski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-06-24       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.